Back to search

Article

Low skeletal muscle radiodensity predicts response to avelumab maintenance treatment in patients with metastatic urothelial carcinoma

2026-01-27

Abstract excerpt

<title>Abstract</title> <p> <bold>Background:</bold> The JAVELIN Bladder 100 trial demonstrated a significant survival benefit of avelumab maintenance therapy over best supportive care in patients with locally advanced or metastatic urothelial carcinoma (la/mUC) who achieved disease control after platinum-based chemotherapy. Although avelumab maintenance therapy is generally well tolerated, some patients experi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8465b9a2-d607-5305-99ee-9252b240a068
DOI
10.21203/rs.3.rs-8486641/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Low skeletal muscle radiodensity predicts response to avelumab maintenance treatment in patients with metastatic urothelial carcinomaDOI 10.21203/rs.3.rs-8486641/v1
Select a neighboring publication to make it the new centre.